Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about LSD Therapy Recent news which mentions LSD Therapy Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow March 27, 2024 Tickers MNMD NEWS Tags Legal FDA Psychedelic/Assisted Therapies From Benzinga MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds March 08, 2024 Tickers MNMD NEWS Tags Financing Management Psychedelic/Assisted Therapies From Benzinga MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials March 07, 2024 Tickers CMPS MNMD NEWS Tags Breakthrough Therapy Drug News Market News From Benzinga MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses February 28, 2024 Tickers MNMD Tags Psychedelics Benzinga Biotech From Benzinga MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued January 11, 2024 Tickers MNMD NEWS Tags Markets Market News Cannabis From Benzinga Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time August 23, 2023 Tags General Psychedelic/Assisted Therapies Benzinga From Benzinga BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives June 28, 2023 Tickers BETRF PHRRF Tags Psychedelics Benzinga FDA From Benzinga Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study June 05, 2023 Tickers CMPS MNMD NUMIF Tags CMPS Small Cap Psychedelic/Assisted Therapies From Benzinga MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens May 30, 2023 Tickers MNMD Tags Proxy fight FCM MM Holdings Psychedelic/Assisted Therapies From Benzinga MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected May 19, 2023 Tickers MNMD Tags Psychedelic/Assisted Therapies Management MNMD From Benzinga MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections May 05, 2023 Tickers MNMD Tags Psychedelic/Assisted Therapies MNMD Benzinga From Benzinga 80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial April 17, 2023 Tickers MNMD Tags Management General University Hospital Basel From Benzinga LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light January 13, 2023 Tags Markets Market News Cannabis From Benzinga Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More November 29, 2022 Tickers AWKNF CMND CMPS PSIL Tags PSYK Psychedelic/Assisted Therapies Small Cap From Benzinga MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials November 11, 2022 Tickers MNMD Tags LSD Therapy Markets Market News From Benzinga LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress November 04, 2022 Tickers BLRZF Tags Benzinga Psychedelics Microdosing From Benzinga Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives September 27, 2022 Tickers BETRF Tags Psychedelics Penny Stocks Benzinga From Benzinga This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety September 08, 2022 Tickers MNMD Tags LSD Therapy Cannabis Biological Psychiatry From Benzinga Connecting To Nature Through Psychedelics April 17, 2022 Tickers TECH Tags Tech Nature Psychedelics From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.